2. Academic Validation
  3. Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents

Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents

  • Bioorg Med Chem. 2008 Dec 1;16(23):10098-105. doi: 10.1016/j.bmc.2008.10.023.
Mario Alvarado 1,  Pilar Goya,  Manuel Macías-González,  Francisco Javier Pavón,  Antonia Serrano,  Nadine Jagerovic,  Jose Elguero,  Angel Gutiérrez-Rodríguez,  Santiago García-Granda,  Margarita Suardíaz,  Fernando Rodríguez de Fonseca
Affiliations

Affiliation

  • 1 Instituto de Química Médica, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain.
PMID: 18952442 DOI: 10.1016/j.bmc.2008.10.023
Abstract

Searching for new antiobesity agents, a new series of fatty acid amide derivatives of 1,5-diarylpyrazole have been synthesized as dual peroxisome proliferator activated receptor alpha (PPARalpha)/Cannabinoid Receptor ligands. The compounds have been evaluated in vivo and in vitro as PPARalpha activators and as cannabinoids in two tests of the mouse tetrad. In vivo, food intake studies have been performed with all the compounds. No significant cannabinoid activity has been found but some compounds behaved as potent PPARalpha activators. Several compounds showed anorexigenic properties reducing food intake in rats.

Figures